태어나기 전의 유대감: 초산 예정 부부를 위한 모바일 헬스 개입 (B³)
출산 전 유대감 형성: 임신 부부의 마음챙김과 정서 조절 개발을 위한 클러스터 무작위 대조군 mHealth 임상시험
Emotional regulation is a key component of reducing parenting stress, a sense of self-efficacy, and thus successful parenting, child outcomes, and productivity amongst working parents. However, few interventions begin building these necessary components in pregnancy prior to the extremely stressful period immediately post-partum, where little trait and behavioural modification occurs. More importantly, most interventions overlook the importance of having both partners, despite fathers/partners playing a significant role in influencing maternal stress and mood symptoms.
This goal of this study is to examine whether short weekly exercises delivered through a mobile app can help first-time parents feel better emotionally during pregnancy. These exercises are designed to help people manage their emotions and stress. Researchers want to know if doing these exercises, along with getting weekly feedback and encouragement, can reduce signs of depression and improve emotional control.
Expecting mothers and fathers who are having their first child may be able to join the study if they meet certain conditions. Participants should be planning to stay in Singapore for the next two years and be comfortable using a smartphone and answering questions in English. Participants may benefit from learning new ways to manage stress and emotions, which could help improve their mental health.
Participants will wear a Fitbit watch to track activity. They will complete a short weekly survey about their well-being during pregnancy and a monthly survey about their work productivity until six months after the baby is born. They will also answer online surveys about their health, relationships, and background at the start, three times during pregnancy, and three times after birth. In addition, they will visit the research lab twice to take part in tasks that measure thinking and behaviour.
연구 개요
상세 설명
The overall goal of this study is to answer the following main questions:
- Does the intervention improve parents' depressive symptoms scores, using the Edinburgh Postnatal Depression Scale as a proxy?
- Does the intervention improve parents' emotional regulation skills?
The study involves 286 expectant couples (572 individuals) in a two-arm, cluster-randomized controlled trial with longitudinal observational follow-up until the child turns 6 months old. The active intervention comprises of customized, weekly recommendations of short (2-5 minute) audio clips featuring activities such as breathing exercises, meditation, mindful walking. These will be provided to adult participants (expectant couples). Couples enrolling in the study will randomly be allocated to either the control or intervention group by prespecified block sizes of 10. That is, a random number generator will be used to preset the assignments in groups of 10, such that every 10 consecutive enrolments will have exactly 5 controls and 5 interventions (1:1 allocation). While it is not possible to blind operational staff to assignments (different protocols to follow, highly unbalanced assignment), scheduling of enrolment visits will be done by different staff than those conducting the enrolment visits, and the assignment will only be made known to enrolment staff while conducting the visit itself and they will also not have access to the blocking and randomization algorithm.
Participants in the control, no-intervention group will have access to a mobile app with similar functions as the participants in the intervention group, except that no personalized modules are given. Data will also be collected from online and in-app surveys, as well as via the Fitbit watch.
Participants in the intervention group will have access to the mHealth app that will be installed on their mobile devices and have access to weekly personalized recommendations. Participants will also be re-randomized weekly to different modules within the app. Data will also be collected from online and in-app surveys, as well as via the Fitbit watch.
The intervention will take place throughout pregnancy, beginning at enrollment ( when the mother is less than 20 gestational weeks of pregnancy), and continuing until the child is born. As gestational duration varies among participants, the total intervention period will range approximately from 17 to 28 weeks, depending on the timing of recruitment and delivery. All study arms will be assessed up to 6 months after birth.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Santhi Ponmudi, MPh
- 전화번호: +65-64070100
- 이메일: santhi_ponmudi@a-star.edu.sg
연구 장소
-
-
-
Singapore, 싱가포르, 117609
- 모병
- Institute for Human Development and Potential (IHDP), Singapore
-
연락하다:
- Santhi Ponmudi, MPh
- 전화번호: +65-64070100
- 이메일: santhi_ponmudi@a-star.edu.sg
-
수석 연구원:
- Michelle Z.L Kee, PhD
-
수석 연구원:
- Cornelia Y.I Chee, MBBS, MMed
-
수석 연구원:
- Bibhas Chakraborty, PhD
-
부수사관:
- Xiaoxi Yan, PhD
-
부수사관:
- Evelyn C Law, MD
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
Mothers:
- 21-50 years of age
- Less than 20 weeks of pregnancy, confirmed by ultrasonography upon enrolment
- Singleton pregnancy
- Nulliparous
- Plan to deliver in Singapore
- Proficient and able to respond to questionnaires in English
- Intends for herself and her child to stay in Singapore for the next 2 years
- Access to a smartphone
- Willing to download the study app
- Score of 7 or more in the Edinburgh Postnatal Depression Scale
Fathers:
- 21-75 years of age
- Proficient and able to respond to questionnaires in English
- Intends for himself and his child to stay in Singapore for the next 2 years
- Access to a smartphone
- Willing to download the study app
Exclusion Criteria:
Mothers:
- Any pre-existing or history of psychotic depression, schizophrenia, and bipolar disorders
- Currently on oral/IV steroids and/or thyroid medication
- History of thyroid disease
- Pregnant using assisted reproductive technologies
- Multiple pregnancies
- Currently enrolled in interventional randomised controlled trials
- Responded "Yes, quite often" to EPDS item 10 ("The thought of harming myself has occurred to me")
Fathers:
1. Currently enrolled in interventional randomised controlled trials
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
간섭 없음: Group A (Control)
Participants' will have access to a mobile app with similar functions as the participants in the intervention group, except that there are no personalized modules given. Data will also be collected from online and in-app surveys, as well as via the Fitbit watch. |
|
|
실험적: Group B (Intervention)
Participants have access to the mHealth app that will be installed on their mobile devices and have access to weekly personalized recommendations. Data will also be collected from online and in-app surveys, as well as via the Fitbit watch. |
Participants in the intervention group will receive recommended modules in the mHealth app installed on their phones. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Parents' Depressive Symptoms
기간: Administered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months. The average of the three postnatal EPDS measurements will be used as the primary outcome assessment
|
Parents' level of depressive symptoms will be measured using the Edinburgh Postnatal Depression Scale. |
Administered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months. The average of the three postnatal EPDS measurements will be used as the primary outcome assessment
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Parents' emotional regulation skills
기간: Administered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months.
|
Examining self-reported parental emotional regulation skills using the Cognitive Emotion Regulation Questionnaire |
Administered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months.
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Michelle Z.L Kee, PhD, Institute for Human Development and Potential
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- 2026-049
- H22P0M0001 (기타 보조금/기금 번호: A*STAR Human Health and Potential Prenatal/Early Childhood Grant)
- H22P0M0009 (기타 보조금/기금 번호: A*STAR Human Health and Potential Prenatal/Early Childhood Grant)
- NUHSRO/2025/082/NUSMed/024/B3 (기타 보조금/기금 번호: National University of Singapore)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
The decision regarding the availability of individual participant data for sharing requires further discussions between the institutes.
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .